More information on the PharmedOut conference
Via email from Adriane Fugh-Berman, selected abstracts for talks to be given at the third annual PharmedOut conference June14-15 at Georgetown University. Please see my previous post for more...
View Article“Be Brave”
In January, I blogged about an open letter by Harlan Krumholz and Rodney Hayward to the panel that is currently engaged in writing new guidelines for cholesterol management. As discussed in my post,...
View ArticleAlzheimer’s disease, familial hypercholesterolemia, and clinical trials
Welcome Jesse Ballenger to the blogosphere. Jesse is a historian who specializes in the history of medicine and is the author of Self, Senility and Alzheimer’s Disease in Modern America. Gary...
View ArticleCompare and contrast: two review articles on ezetimibe
For the past several years I have been following the ezetimibe controversy (see these posts on Gooznews and this blog here, here, here, here, here, here, here, here, here, here, here, here, here, here,...
View ArticleArticle in Korean Circulation Journal retracted for plagiarism
In March of this year, Larry Husten reported on CardioBrief that a review article in the Korean Circulation Journal by Chang Gyu Park and Ju Young Lee appeared to plagiarize from a review article in...
View ArticleJohns Hopkins to launch Center for Drug Safety and Effectiveness
Johns Hopkins is launching a new Center for Drug Safety and Effectiveness. Via G. Caleb Alexander, On Wednesday, October 24, we will launch the Johns Hopkins Center for Drug Safety and Effectiveness,...
View ArticleBen Goldacre on missing data and publication bias
Ben Goldacre at Strata Conference Here is a video of Ben Goldacre speaking at the Strata Conference in London earlier this month (H/T Chris Southan). I also recommend his book, Bad Pharma: How drug...
View ArticleBMJ editor: Open letter to Roche about oseltamivir trial data
In BMJ: Roche promised in 2009 to release full reports from clinical trials of oseltamivir in response to an investigation by the BMJ and the Cochrane Collaboration. In this open letter to John Bell,...
View ArticleBMJ: Clinical trial data for all drugs in current use must be available for...
In an impassioned editorial, BMJ editor Fiona Godlee calls on the pharmaceutical industry to release clinical trial data on all approved drugs, and on medical journals to publish industry-funded trials...
View ArticleShould a former drug company executive be CEO of the American College of...
Last week, the American College of Cardiology announced that it had named Shalom Jacobovitz as its CEO. Since 2004, Jacobovitz has served as president of Actelion Pharmaceuticals U.S., Inc., the U.S....
View ArticleSociety for Participatory Medicine Tweetchat Series
The Society for Participatory Medicine is launching a tweetchat series this Saturday, Sept. 14 at 3pm EST. The chat will be led by Casey Quinlan (@MightyCasey); Ileana Balcu (@Yogileana); and Carla...
View ArticlePerspective in Circulation: Cardiovascular Quality and Outcomes
Recently, I joined the editorial board of Circulation: Cardiovascular Quality and Outcomes, the American Heart Association journal that focuses on quality of care and outcomes research. As my readers...
View ArticleNew series of articles in Circulation: Cardiovascular Quality and Outcomes
Circulation: Cardiovascular Quality and Outcomes will be publishing a new series of articles called narratives, which will be written by patients or by their family, friends or caregivers. Narratives:...
View ArticleAssessment 2020 blog
I am a member of the Assessment 2020 task force of the American Board of Internal Medicine (ABIM). The task force is looking at how to improve the assessment of physicians for purposes of board...
View ArticleMy new Walking Gallery jacket
https://twitter.com/ReginaHolliday/status/454373909647720448 Welcome to #theWalkingGallery @MarilynMann with your jacket “Shared Decision Making.” pic.twitter.com/P3XeE07QbZ — Regina Holliday...
View ArticleMaking health care more patient-centered
I have a post up on the Assessment 2020 blog on how to increase patient involvement in medical decision making. I focus on shared decision making and argue that physicians need to develop certain...
View ArticleBen Goldacre on missing data and publication bias
Ben Goldacre at Strata Conference Here is a video of Ben Goldacre speaking at the Strata Conference in London earlier this month (H/T Chris Southan). I also recommend his book, Bad Pharma: How drug...
View ArticleBMJ editor: Open letter to Roche about oseltamivir trial data
In BMJ: Roche promised in 2009 to release full reports from clinical trials of oseltamivir in response to an investigation by the BMJ and the Cochrane Collaboration. In this open letter to John Bell,...
View ArticleBMJ: Clinical trial data for all drugs in current use must be available for...
In an impassioned editorial, BMJ editor Fiona Godlee calls on the pharmaceutical industry to release clinical trial data on all approved drugs, and on medical journals to publish industry-funded trials...
View Article
More Pages to Explore .....